Its endometriosis awareness week (3rd to 11th March)
Endometriosis and HRT -
European Society of Human Reproduction and Embryology Guidelines -
Management of women with endometriosis - eshre
https://www.eshre.eu/.../Guidelines/Endometriosis/ESHRE-guideline-on-endometriosis...
In women with surgically induced menopause because of endometriosis, estrogen/progestagen therapy or tibolone can be effective for the treatment of menopausal symptoms. The guideline development group (GDG) recommends that in postmenopausal women after hysterectomy and with a history of endometriosis, clinicians should avoid unopposed estrogen treatment. However, the theoretical benefit of avoiding disease reactivation and malignant transformation of residual disease should be balanced against the increased systemic risks associated with combined estrogen/progestagen or tibolone.
The GDG recommends that clinicians continue to treat women with a history of endometriosis after surgical menopause with combined estrogen/progestagen or tibolone, at least up to the age of natural menopause. |
|
|
